221 related articles for article (PubMed ID: 35443747)
41. Resilience of Spike-Specific Immunity Induced by COVID-19 Vaccines against SARS-CoV-2 Variants.
Ballesteros-Sanabria L; Pelaez-Prestel HF; Ras-Carmona A; Reche PA
Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625733
[TBL] [Abstract][Full Text] [Related]
42. A potently neutralizing anti-SARS-CoV-2 antibody inhibits variants of concern by binding a highly conserved epitope.
VanBlargan L; Adams L; Liu Z; Chen RE; Gilchuk P; Raju S; Smith B; Zhao H; Case JB; Winkler ES; Whitener B; Droit L; Aziati I; Shi PY; Creanga A; Pegu A; Handley S; Wang D; Boon A; Crowe JE; Whelan SPJ; Fremont D; Diamond M
bioRxiv; 2021 Apr; ():. PubMed ID: 33907753
[TBL] [Abstract][Full Text] [Related]
43. Preclinical evaluation of ISH0339, a tetravalent broadly neutralizing bispecific antibody against SARS-CoV-2 with long-term protection.
Yang H; Chen Y; Jiang D; Feng X; Xu Y; Wei J; Zou Q; Yang Q; Chen J; Jiang X; Qin C; Huang Z; Wu C; Zhou Y; Li M; Yin L
Antib Ther; 2023 Apr; 6(2):97-107. PubMed ID: 37077474
[TBL] [Abstract][Full Text] [Related]
44. A potent neutralizing antibody provides protection against SARS-CoV-2 Omicron and Delta variants via nasal delivery.
Zhang X; Zhang H; Li T; Chen S; Luo F; Zhou J; Zheng P; Song S; Wu Y; Jin T; Tang N; Jin A; Yang C; Cheng G; Gong R; Chiu S; Huang A
Signal Transduct Target Ther; 2022 Aug; 7(1):301. PubMed ID: 36042204
[TBL] [Abstract][Full Text] [Related]
45. Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages.
Xia S; Wang L; Zhu Y; Lu L; Jiang S
Signal Transduct Target Ther; 2022 Jul; 7(1):241. PubMed ID: 35853878
[TBL] [Abstract][Full Text] [Related]
46. Elicitation of Broadly Neutralizing Antibodies against B.1.1.7, B.1.351, and B.1.617.1 SARS-CoV-2 Variants by Three Prototype Strain-Derived Recombinant Protein Vaccines.
Yang Y; Zang J; Xu S; Zhang X; Yuan S; Wang H; Lavillette D; Zhang C; Huang Z
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452287
[TBL] [Abstract][Full Text] [Related]
47. Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617.
Peng L; Hu Y; Mankowski MC; Ren P; Chen RE; Wei J; Zhao M; Li T; Tripler T; Ye L; Chow RD; Fang Z; Wu C; Dong MB; Cook M; Wang G; Clark P; Nelson B; Klein D; Sutton R; Diamond MS; Wilen CB; Xiong Y; Chen S
bioRxiv; 2021 Dec; ():. PubMed ID: 34981065
[TBL] [Abstract][Full Text] [Related]
48. Co-display of diverse spike proteins on nanoparticles broadens sarbecovirus neutralizing antibody responses.
Brinkkemper M; Veth TS; Brouwer PJM; Turner H; Poniman M; Burger JA; Bouhuijs JH; Olijhoek W; Bontjer I; Snitselaar JL; Caniels TG; van der Linden CA; Ravichandran R; Villaudy J; van der Velden YU; Sliepen K; van Gils MJ; Ward AB; King NP; Heck AJR; Sanders RW
iScience; 2022 Dec; 25(12):105649. PubMed ID: 36439375
[TBL] [Abstract][Full Text] [Related]
49. Differential escape of neutralizing antibodies by SARS-CoV-2 Omicron and pre-emergent sarbecoviruses.
Wang LF; Tan CW; Chia WN; Zhu F; Young B; Chantasrisawad N; Hwa SH; Yeoh AY; Lim BL; Yap WC; Pada SK; Tan SY; Jantarabenjakul W; Chen S; Zhang J; Mah YY; Chen V; Chen M; Wacharapluesadee S; ; Putcharoen O; Lye D
Res Sq; 2022 Feb; ():. PubMed ID: 35233568
[TBL] [Abstract][Full Text] [Related]
50. Structural basis for broad sarbecovirus neutralization by a human monoclonal antibody.
Tortorici MA; Czudnochowski N; Starr TN; Marzi R; Walls AC; Zatta F; Bowen JE; Jaconi S; di Iulio J; Wang Z; De Marco A; Zepeda SK; Pinto D; Liu Z; Beltramello M; Bartha I; Housley MP; Lempp FA; Rosen LE; Dellota E; Kaiser H; Montiel-Ruiz M; Zhou J; Addetia A; Guarino B; Culap K; Sprugasci N; Saliba C; Vetti E; Giacchetto-Sasselli I; Silacci Fregni C; Abdelnabi R; Caroline Foo SY; Havenar-Daughton C; Schmid MA; Benigni F; Cameroni E; Neyts J; Telenti A; Snell G; Virgin HW; Whelan SPJ; Bloom JD; Corti D; Veesler D; Pizzuto MS
bioRxiv; 2021 Apr; ():. PubMed ID: 33851169
[TBL] [Abstract][Full Text] [Related]
51. A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern
Chiem K; Morales Vasquez D; Silvas JA; Park JG; Piepenbrink MS; Sourimant J; Lin MJ; Greninger AL; Plemper RK; Torrelles JB; Walter MR; de la Torre JC; Kobie JK; Ye C; Martinez-Sobrido L
J Virol; 2021 Oct; 95(22):e0112621. PubMed ID: 34495697
[TBL] [Abstract][Full Text] [Related]
52. An Engineered IgG-VHH Bispecific Antibody against SARS-CoV-2 and Its Variants.
Chi H; Wang L; Liu C; Cheng X; Zheng H; Lv L; Tan Y; Zhang N; Zhao S; Wu M; Luo D; Qiu H; Feng R; Fu W; Zhang J; Xiong X; Zhang Y; Zu S; Chen Q; Ye Q; Yan X; Hu Y; Zhang Z; Yan R; Yin J; Lei P; Wang W; Lang G; Shao J; Deng Y; Wang X; Qin C
Small Methods; 2022 Dec; 6(12):e2200932. PubMed ID: 36300882
[TBL] [Abstract][Full Text] [Related]
53. A VHH single-domain platform enabling discovery and development of monospecific antibodies and modular neutralizing bispecifics against SARS-CoV-2 variants.
Yang ML; Yuan TZ; Chan KY; Ding L; Han Z; Franco H; Holliday C; Kannan S; Davidson E; Doranz BJ; Chandran K; Miller EH; Plante JA; Weaver SC; Cho E; Kailasan S; Marsalek L; Giang H; Abdiche Y; Sato AK
Antib Ther; 2024 Apr; 7(2):164-176. PubMed ID: 38933534
[TBL] [Abstract][Full Text] [Related]
54. Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine.
Coléon S; Wiedemann A; Surénaud M; Lacabaratz C; Hue S; Prague M; Cervantes-Gonzalez M; Wang Z; Ellis J; Sansoni A; Pierini C; Bardin Q; Fabregue M; Sharkaoui S; Hoest P; Dupaty L; Picard F; El Hajj M; Centlivre M; Ghosn J; ; Thiébaut R; Cardinaud S; Malissen B; Zurawski G; Zarubica A; Zurawski SM; Godot V; Lévy Y
EBioMedicine; 2022 Jun; 80():104062. PubMed ID: 35594660
[TBL] [Abstract][Full Text] [Related]
55. Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccines.
Lu L; Chen LL; Zhang RR; Tsang OT; Chan JM; Tam AR; Leung WS; Chik TS; Lau DP; Choi CY; Fong CH; Cai JP; Tsoi HW; Choi CY; Zhang X; Abdullah SMU; Chan BP; Chan KH; Yuen KY; Hung IF; To KK
EBioMedicine; 2022 May; 79():103986. PubMed ID: 35398786
[TBL] [Abstract][Full Text] [Related]
56. Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses.
Radić L; Sliepen K; Yin V; Brinkkemper M; Capella-Pujol J; Schriek AI; Torres JL; Bangaru S; Burger JA; Poniman M; Bontjer I; Bouhuijs JH; Gideonse D; Eggink D; Ward AB; Heck AJR; Van Gils MJ; Sanders RW; Schinkel J
iScience; 2023 Apr; 26(4):106540. PubMed ID: 37063468
[TBL] [Abstract][Full Text] [Related]
57. Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccination.
Chi X; Guo Y; Zhang G; Sun H; Zhang J; Li M; Chen Z; Han J; Zhang Y; Zhang X; Fan P; Zhang Z; Wang B; Zai X; Han X; Hao M; Fang T; Xu J; Wu S; Chen Y; Fang Y; Dong Y; Sun B; Zhang J; Li J; Zhao G; Yu C; Zhou Q; Chen W
Signal Transduct Target Ther; 2022 Apr; 7(1):139. PubMed ID: 35478188
[TBL] [Abstract][Full Text] [Related]
58. An antibody cocktail with broadened mutational resistance and effective protection against SARS-CoV-2.
Sun C; Chi H; Yuan F; Li J; Yang J; Zheng A; Wang F; Sun L; Zhang Y; Hu P; Jiao L; Deng Y; Xie L
Sci China Life Sci; 2023 Jan; 66(1):165-179. PubMed ID: 36184693
[TBL] [Abstract][Full Text] [Related]
59. An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants.
Chi X; Zhang X; Pan S; Yu Y; Shi Y; Lin T; Duan H; Liu X; Chen W; Yang X; Chen L; Dong X; Ren L; Ding Q; Wang J; Yang W
Signal Transduct Target Ther; 2022 Feb; 7(1):44. PubMed ID: 35140196
[TBL] [Abstract][Full Text] [Related]
60. An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses.
Liu L; Iketani S; Guo Y; Reddem ER; Casner RG; Nair MS; Yu J; Chan JF; Wang M; Cerutti G; Li Z; Morano NC; Castagna CD; Corredor L; Chu H; Yuan S; Poon VK; Chan CC; Chen Z; Luo Y; Cunningham M; Chavez A; Yin MT; Perlin DS; Tsuji M; Yuen KY; Kwong PD; Sheng Z; Huang Y; Shapiro L; Ho DD
Sci Transl Med; 2022 May; 14(646):eabn6859. PubMed ID: 35438546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
